Unique ID issued by UMIN | UMIN000024946 |
---|---|
Receipt number | R000028626 |
Scientific Title | Elucidation of pathophysiology and treatment of aquagenic wrinkling of the palms |
Date of disclosure of the study information | 2016/11/30 |
Last modified on | 2018/04/16 10:24:44 |
Elucidation of pathophysiology and treatment of aquagenic wrinkling of the palms
Elucidation of pathophysiology and treatment of aquagenic wrinkling of the palms
Elucidation of pathophysiology and treatment of aquagenic wrinkling of the palms
Elucidation of pathophysiology and treatment of aquagenic wrinkling of the palms
Japan |
Aquagenic wrinkling of the palms, palmoplantar keratoderma, palmoplantar hyperhidrosis, healthy subjects
Dermatology | Adult | Child |
Others
NO
To elucidate the pathophysiological mechanism that aquagenic wrinkling occurs by comparing the skin between aquagenic wrinkling of the palms, palmoplantar keratoderma, palmoplantar hyperhidrosis and healthy subjects. And also, assessing the safety and efficacy of treatment with non-steroidal anti-inflammatory analgesics by external application.
Safety,Efficacy
Evaluate degree of maceration before and after water immersion test on each visit.
Observe the morphology of the palmar skin with an ultrasonic microscope (at the start and the end of the test). Create and compare replica of finger skin print before and after water immersion test (as much as possible on each visit). Self assessment of skin symptoms (per visit).
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
Medicine |
Loxoprofen sodium hydrate tape, once a day, pasted on the fingers for 3 to 6 months, 1% diclofenac sodium gel and lotion, topical application to the palm for 3 to 6 months twice a day, 20% or 30% aluminum chloride solution, topical application to the palm for 3 to 6 months twice a day
6 | years-old | <= |
Not applicable |
Male and Female
Patients who have skin maceration by exposure to water with Aquagenic wrinkling of the palms, palmoplantar keratoderma and palmoplantar hyperhidrosis, and healthy subjects
1) Patients who can not inform disease name.
2) Patients with aspirin asthma and a previous medical history of it.
3) Patients with a history of hypersensitivity to diclofenac sodium, sodium loxoprofen hydrate.
4) Case of pregnancy or expected pregnancy (hope / plan)
5) Cases with age less than 6 at the time of consent acquisition
6) Patients who are judged inappropriate by doctors.
50
1st name | |
Middle name | |
Last name | Akiharu Kubo |
Keio university school of medicine
Department of dermatology
35 Shinanomachi, Shinjuku-ku, Tokyo
03-3353-1211(62413)
akiharu@keio.jp
1st name | |
Middle name | |
Last name | Akiharu Kubo |
Keio university school of medicine
Department of dermatology
35 Shinanomachi, Shinjuku-ku, Tokyo
03-3353-1211(62413)
akiharu@keio.jp
Keio university school of medicine, Department of dermatology
Keio university school of medicine, Department of dermatology
Other
Tohoku University Graduate School of Biomedical Engineering
NO
2016 | Year | 11 | Month | 30 | Day |
Unpublished
Terminated
2016 | Year | 10 | Month | 05 | Day |
2016 | Year | 11 | Month | 30 | Day |
2016 | Year | 11 | Month | 22 | Day |
2018 | Year | 04 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028626